These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28330821)

  • 1. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Choi YY; Cheong JH
    Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From standard to new genome-based therapy of gastric cancer.
    Lianos GD; Mangano A; Cho WC; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1023-6. PubMed ID: 26108988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic options opened by the molecular classification of gastric cancer.
    Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
    World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.
    Choi YY; Noh SH; Cheong JH
    Yonsei Med J; 2015 Sep; 56(5):1177-85. PubMed ID: 26256958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritizing therapeutic targets using patient-derived xenograft models.
    Lodhia KA; Hadley AM; Haluska P; Scott CL
    Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric carcinoma: an evolutionary scenario.].
    Gelsomino F; Spallanzani A; De Vita F; Di Bartolomeo M; Gavazzi C; Rimassa L; Cascinu S
    Recenti Prog Med; 2017 Mar; 108(3):120-127. PubMed ID: 28398405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards curative therapy in gastric cancer: Faraway, so close!
    Cravo M; Fidalgo C; Garrido R; Rodrigues T; Luz G; Palmela C; Santos M; Lopes F; Maio R
    World J Gastroenterol; 2015 Nov; 21(41):11609-20. PubMed ID: 26556990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Xenograft Models for Endometrial Cancer Research.
    Moiola CP; Lopez-Gil C; Cabrera S; Garcia A; Van Nyen T; Annibali D; Fonnes T; Vidal A; Villanueva A; Matias-Guiu X; Krakstad C; Amant F; Gil-Moreno A; Colas E
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into next developments in advanced gastric cancer.
    Obermannová R; Lordick F
    Curr Opin Oncol; 2016 Jul; 28(4):367-75. PubMed ID: 27092990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of gastric cancer.
    Röcken C
    Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The journey of personalizing gastric cancer treatment.
    Yan L
    Chin J Cancer; 2016 Aug; 35(1):84. PubMed ID: 27581614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.
    Tian H; Zhou C; Yang J; Li J; Gong Z
    Tumour Biol; 2017 Apr; 39(4):1010428317697578. PubMed ID: 28381159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.